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Abstract: In Brazil, Imunoparvum
R°
is used as an immunomodulator. It is commercial-
ized in 2 ml ampoules containing 2 mg of Propionebacterium acnes (formerly known as
Corynebacterium parvum)/ml, in a 0.5 % phenol and 0.85% sodium chloride solution. High
therapeutic power associated to minimum side eﬀects is a great challenge to the pharma-
ceutical industry. Research results have shown that Imunoparvum
R°
induces side eﬀects in
humans and animals, probably because of its phenol content (SOUSA, 1993; RODRIGUES,
2001). The objective of this study was to determine the phenol content of lyophilized and
non-lyophilized Imunoparvum
R°
and to compare their side eﬀects in mice. It was demon-
strated that the lyophilization process reduces the phenol content and the side eﬀects of
Imunoparvum
R°
, when compared to the commercialized Propionebacterium acnes suspen-
sion.
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Resumo: No Brasil, o Imunoparvum
R°
e´ usado como imunomodulador. E´ envasado em am-
polas contendo 2 mg/ml de Propioniobacterium acnes (antigo Corynebacterium parvum) em
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uma suspensa˜o de cloreto de so´dio contendo 0,5 % de fenol. Um aumento da sua eficieˆncia
terapeˆutica associada a` diminuic¸a˜o dos seus efeitos colaterais e´ um grande desafio a` indu´stria
farmaceˆutica. Pesquisas teˆm mostrado que o Imunoparvum
R°
induz efeitos colaterais em
humanos e em animais, provavelmente em virtude da presenc¸a do fenol como parte inte-
grante da formulac¸a˜o comercial (SOUSA, 1993; RODRIGUES, 2001). O objetivo deste
estudo foi analisar as concentrac¸o˜es de fenol no Imunoparvum
R°
em suspensa˜o apo´s sub-
meteˆ-lo a processo de liofilizac¸a˜o, comparando os seus efeitos colaterais em camundongos.
Os resultados encontrados no presente modelo revelaram que a liofilizac¸a˜o reduziu tanto os
teores de fenol quanto os efeitos colaterais, quando comparados a` forma em suspensa˜o.
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1 Introduction
Evidence has shown that P. acnes is capable of enhancing the immune response
in human and animals, modulating the resistance to infections and increasing the ef-
ficiency when associated at conventional therapy of several diseases (CASTRO, 1974,
TEIXEIRA, 1996, SOUSA, 1993, AEBISCHER, 2000). There are, however, several re-
ports of human patients treated with P. acnes that developed adverse eﬀects, such
as pain after injection, skin irritation, fever and systemic shock. These observations
are in agreement with the side eﬀects observed in mice immediately after inoculation
with suspension of P. acnes (SOUSA, 1993). Evidence demonstrated that these side
eﬀects have origin in the production of the vaccine, which maintain a high concentra-
tion of phenol in the formulation (SOUSA, 1993, RODRIGUES, 2001). The objective
of this work was to use the lyophilization process as means to neutralize the phenol
level in the suspension of Imunoparvum
R°
after industrialization in order to reduce
its side eﬀects.
2 Methods
2.1 Determination of phenol content and cell concentration of
P. acnes in Imunoparvum R°
Non-lyophilized Imunoparvum
R°
(NLI) suspension sample from 2 ml am-
poule was filtered in sintered glass micro filter (5 ml capacity and porosity number
3). The resulting filtered solution was completed to one liter by the addition of dis-
tilled and deionized water (dd-water) and the solid phase was discarded. Lyophilized
Imunoparvum
R°
(LI) 4 mg samples were suspended in 5 ml of dd-water followed by
a 30-minute period in a magnetic stirring apparatus. Then, the solution was filtered
in sintered glass micro filter (5 ml capacity and porosity number 3) and the filtered
solution was diluted to 50 ml of dd-water. Phenic acid concentration was determined
by UV/VIS spectroscopy, measured at 210 nm wavelength, based on a 190 to 500
nm range scanning of a phenol standard solution, using dd-water as the reference.
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Quality control tests were based in 100 ampoules of NLI and 100 ampoules of LI.
The studied characteristics were the final volume, pH, aspect of the ampoule con-
tent, mean weight, phenol research by ferric acid method, syringe flow and P. acnes
cell concentration, performed on both NLI and LI samples, in order to evaluate the
eﬀect of the lyophilization process.
2.2 In vivo trials
In vivo side-eﬀects trials were carried out in nine groups of five Swiss mice.
Each animal received a single 0.2 ml intra peritoneal dose. Group 1 mice received
each one 0.2 mg of NLI solution. Groups 2, 3 and 4 mice received, respectively, 0.2
mg, 0,4 mg, and 1 mg of LI, dissolved in a 0.85% sodium chloride solution. Each
mice from group 5 received 0.2 ml of a 0.85% sodium chloride solution with 0.5 %
phenol concentration. Animals from groups 6 to 9 received 0.2 ml diluted (1/10,
1/100, 1/1000 and 1/10000, respectively) doses of the solution used in group 5 mice.
Mice were observed during 72 hours after drug administration.
3 Results and discussion
A phenol solution, 0.0268 g/l, was submitted to a 190 to 500 nm UV/VIS spec-
troscopy scanning (Figure 1, curve 3). Maximum absorbance peaks were observed
at 210 nm (characteristic of aromatic rings) and 270 nm (characteristic of −OH
phenolic groups).
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Figure 1. UV/VIS curves of investigated samples of NLI Non-Filtered (curve 1),
NLI Filtered (curve 2), Phenol Standard (curve 3) and LI (curve 4).
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Figure 2. Standard curve used for determination of phenol concentration at 210 nm.
The standard curve was determined using five phenol solutions (535.00; 267.50;
53.50; 26.75 and 5.35 mg/ml). Absorbances were determined at 210 nm (Figure 2).
Estimated linear regression equation was C = −1.964× 10−4 + 18.000× 10−4 ABS
(r2 = 0.998). C is the phenol concentration in g/l, and ABS is the absorbance at
210 nm.
Figure 1 shows the UV/VIS curves of the investigated samples. Results indi-
cate that lyophilization decreases the phenol content of Imunoparvum
R°
(Figure 1,
curve 4). The solid phase of non-filtered NLI showed a hiding eﬀect, as it does
not permit to detect the 210 and 270 nm absorbance peaks observed in the filtered
NLI, necessary to the determination of the phenol concentration (Figure 1, curve 1).
After filtration and elimination of the solid phase, it was observed that the filtered
NLI curve presented two peaks, corresponding to the phenolic absorbance (Figure
1, curve 2). This result indicated the high phenol content in NLI. LI curve (Fig-
ure 1, curve 4) confirms lyophilization eﬃciency in reducing the phenol content of
Imunoparvum
R°
. It was observed that the 0.51% phenol content in NLI was reduced
to 0.004% in LI. The lyophilization process did not aﬀect dry weight, pH, sterility
and syringe flow of the re-hydrated Imunoparvum
R°
(See Table 1).
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Analysis NLI(ml) LI NaCl
(0,85%)
Declared volume 2.00
Actual volume 2.05
pH
Flasks with colorless content 6.26
Flasks with cloudy content 6.27
Supplied salt bed 7.03
Mean weight (mg/ml) 1.842
Variation of mean weight in 40% of the samples (g) 0.0077 − 0.0229
Variation of mean weight in 60% of the samples (g) 0.02004 − 0.0229
Phenol content by ferric chloride method
NLI in natura Flasks Positive
Flasks with colorless content Negative
Flasks content slightly cloudy Fainly positive
Syringe flow Satisfies Satisfies
Table 1. Physical chemical analysis of Imunoparvum R°.
4 Clinical aspects
The 0.2 mg NLI dose caused slight skin irritation in the injection spot, ac-
companied by pain manifested by abdominal contortions, tachypnea, involuntary
urination, and defecation in some of them. The symptoms disappeared within 30 to
40 minutes. Isolation or grouping behavior, depression, sweating and hair bristling
were observed during 5 to 8 hours after drug administration. These same condi-
tions were observed in all mice inoculated with diluted phenol only. Clinical aspects
showed in this experiment are in accordance with Sousa (1993). Animals inoculated
with LI did not present any side eﬀects. Neither NLI nor LI killed the studied mice.
5 Conclusion
Lyophilization reduced the phenol content of Imunoparvum
R°
. The present
study also showed that phenol in high concentration seems to be responsible for the
observed Imunoparvum
R°
side eﬀects in mice.
Acknowledgements
This work was supported by the National Council for Technological and Sci-
entific Development (CNPq) and The Pharmaceutical Laboratory of the State of
Pernambuco (LAFEPE).
78 Revista Cieˆncias Exatas e Naturais, Vol. 4, no 1, Jan/Jun 2002
References
AEBISCHER, T. Subunit vaccination of mice against new word cutaneous Leish-
maniasis : Comparison of three proteins expressed in amastigotes and six
adjuvants. Infection and Imunity, v. 68, n. 3, 2000, p. 1328-1336.
CASTRO, J. E. The eﬀect of Corynebacterium parvum on the struture and function
of the lynphoid system in mice. Europ. J. Cancer. v. 10, 1974, p. 115-120.
RODRIGUES, O. G. Estudo in vitro para avaliac¸a˜o das alterac¸o˜es morfolo´gicas
das ce´lulas HEp2, NCIH-292 e TVT canino produzidas por Imunoparvum
R°
e in
vivo para verificac¸a˜o dos seus efeitos terapeˆuticos, 129 p, 2001. Tese de Doutorado
Universidade Federal de Pernambuco.
SOUSA, M. C. B. B. Influeˆncia da dose e esquema de administrac¸a˜o de C. parvum
inativado, CEPA DAUFPE n. 187, sobre o eritrograma, leucograma e perfil
prote´ico de camundongos, 1993. Tese de Mestrado em Cl´ınica Medicina Veteri-
na´ria, Universidade Federal Rural de Pernambuco.
TEIXEIRA, K. M. COUTINHO, E. M. Eﬀects of non-specific immunopotentiators
in experimental Schistosoma mansoni infection.II. Corynebacterium parvum.
Ver. Inst. Med. Tropi. v. 38, n. 5, 1996, p. 359-363.
